Shares of BTG plc (LON:BTG – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 840 ($10.67) and traded as high as GBX 840 ($10.67). BTG shares last traded at GBX 840 ($10.67), with a volume of 271,742 shares traded.
BTG Stock Performance
The firm has a market cap of £3.26 billion and a P/E ratio of 29.47. The business’s 50-day simple moving average is GBX 840 and its 200 day simple moving average is GBX 840.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Recommended Stories
- Five stocks we like better than BTG
- Breakout Stocks: What They Are and How to Identify Them
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- Trading Halts Explained
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
